News & Views

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy’s ability to improve patients’ mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness.

New Scientist: Why the keto diet could be a revolutionary way to treat mental illness

April 27, 2026—You may think of the high-fat, low-carb eating plan as a faddish way to lose weight. But the keto diet is now being used to tackle conditions from severe depression to bipolar disorder and anorexia, with transformative results.

Psychiatric News: Can the Keto Diet Cure SMI? It’s Complicated.

March 30, 2026—HHS Secretary Robert F. Kennedy Jr. recently said that ketogenic metabolic therapy can ‘cure’ schizophrenia and bipolar disorder. While clinical researchers don’t go nearly that far, they have found that the 100-year-old epilepsy treatment can lead to dramatic improvements in some psychiatric patients.

STAT News: Why this Stanford psychiatrist thinks diet can influence serious mental health disorders

March 30, 2026—Shebani Sethi studies the role of metabolic dysfunction in depression, schizophrenia, and other disorders — a link promoted by MAHA leaders

1 2 3 … 22 >